Global Wealth Management Investment Advisory, Inc. Gilead Sciences, Inc. Transaction History

Global Wealth Management Investment Advisory, Inc.

$429 Million
Q2 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $3,116 - $3,510	54 Added 101.89%	107 $7,000
Q1 2022 May 17, 2022	BUY	$57.92 - $72.58 $1,332 - $1,669	23 Added 76.67%	53 $3,000
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $3,173 - $3,467	-50 Reduced 62.5%	30 $2,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $3,115 - $3,550	-55 Reduced 40.74%	80 $5,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $15,711 - $19,754	-253 Reduced 65.21%	135 $9,000
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $11,212 - $13,020	155 Added 66.52%	388 $30,000
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $3,319 - $4,251	53 Added 29.44%	233 $17,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $3,573 - $3,931	58 Added 47.54%	180 $12,000
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $687 - $759	-11 Reduced 8.27%	122 $8,000
Q2 2019 Aug 20, 2019	SELL	$61.87 - $69.38 $14,786 - $16,581	-239 Reduced 64.25%	133 $9,000
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $22,520 - $29,388	372 New	372 $23,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Wealth Management Investment Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Global Wealth Management Investment Advisory, Inc. with notifications on news.

Account